Central Jersey News Today
| Stories 1 to 5 of 32 |
|
2/5/2012
The Giants have come from behind for the second time in four years to beat the New England Patriots in the Super Bowl. Sunday night at Lucas Oil Stadium in Indianapolis, running back Ahmad Bradshaw scored a touchdown with :57 left to give Big Blue a 21-17 victory in Super Bowl 46. Quarterback Eli Manning, who orchestrated the game-winning 89-yard drive, was named the MVP, as he was in Super Bowl 42. The biggest play of the drive was a 39-yard completion to Mario Manningham who tip-toed the sideline with two defenders on him and kept both feet inbounds while making a superb catch. For Big Blue, it's their fourth Super Bowl title in five tries.
read more
|
2/4/2012
The Rutgers men's basketball team dropped a 78-66 decision at Louisville Saturday afternoon in a Big East game heard on the new talk radio, 1450 WCTC and WCTCAM.com, the Voice of the Scarlet Knights. RU was led by freshman guard Eli Carter who scored 24 points. The Knights fall to 4-7 in league and 12-12 overall.
read more
|
2/4/2012
The 13th-ranked Rutgers women's basketball team lost at number-three Connecticut 66-34 Saturday night in a Big East game heard on the new talk radio, 1450 WCTC and WCTCAM.com, the Voice of the Scarlet Knights. RU falls to 6-4 in league and 17-6 overall. The Knights were led by junioir center Monique Oliver who scored 15 points.
read more
|
2/3/2012
A former executive at the collapsed brokerage MF Global has testified that he warned former governor and then-CEO Jon Corzine a year before the company went under about the risks of making large bets on European government debt. Michael Roseman, who was chief risk officer for the company, told a House oversight subcommittee that he raised the concern in October 2010, as the company's bets on European debt approached $4 billion.
read more
|
2/3/2012
Whitehouse Station-based Merck swung to a fourth-quarter profit because of lower restructuring and other charges and higher sales of most of its key drugs. The world's third-biggest drugmaker forecast little improvement this year, when its top-selling drug, allergy and asthma medicine Singulair, will get U.S. competition from cheaper generic versions. Meanwhile, Merck says it has received U.S. approval for an extended-release version of its diabetes drug Janumet designed to be taken once a day, instead of twice a day. The Food and Drug Administration approved Janumet XR to help patients with type 2 diabetes control their blood sugar levels.
read more
|